Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis

This publication has 39 references indexed in Scilit:

• Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)
  American Heart Journal, 2003
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)
  Published by Elsevier ,2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Gender differences in diurnal triglyceridemia in lean and overweight subjects
  International Journal of Obesity, 2001
• Action of Atorvastatin in Combined Hyperlipidemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications
  European Journal of Clinical Investigation, 1995
• Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma
  Atherosclerosis, 1991
• Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia
  European Journal of Clinical Investigation, 1989